Table 2 Characteristics of outcome variables in patients who went on to be recruited to the phase I trial.

From: A retrospective study of the impact of comorbidity, polypharmacy and demographic factors on patient inclusion and healthcare delivery in phase I oncology trials

 

Mean (SD)

Median [min, max]

Time on trial (days)

116.9 (192.2)

56.0 [0.5, 1645.0]

Number of emergency scans

2.8 (5.6)

1.0 [0.0, 50.0]

Number of emergency admissions

0.2 (0.4)

0.0 [0.0, 2.0]

Length of stays for emergency admissions (days)

0.9 (3.8)

0.0 [0.0, 59.0]